| Application no. and date | 15766274.3 (espacenet) (Federated) (European Patent Register), 20150829 | | Patent/reg. no. and date | DK/EP 3188727, 20221109 | | Publication date | 20170712 | | Priority no. and date | US 201462044856 P, 20140902, US 201562169635 P, 20150602 | | EP pub. no. and date |
EP 3188727 20170712 | | Effective date | | | Applicant/owner | Vanda Pharmaceuticals Inc., 2200 Pennsylvania Ave NW
Suite 300-E
Washington, DC 20037, US | | Applicant ref. no. | 1647326 | | Inventor | POLYMEROPOULOS, Mihael, H., 10627 River's Bend Lane
Potomac, MD 20854, US,
LAVEDAN, Christian, 240 Inverrary Road
Pinehurst, NC 28374, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/343 (2006.01) , A61K 45/06 (2006.01) , A61P 25/20 (2006.01) , A61P 43/00 (2006.01) | | Title | TASIMELTEON TIL BEHANDLING AF SMITH-MAGENIS¿ SYNDROM | | Int. application no. | US2015047610 | | Int. publication no. | WO2016036619 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
